CN102861287B - 一种治疗湿热下注淤血型糖尿病足的中药组合物及其制备方法 - Google Patents
一种治疗湿热下注淤血型糖尿病足的中药组合物及其制备方法 Download PDFInfo
- Publication number
- CN102861287B CN102861287B CN201210310306.8A CN201210310306A CN102861287B CN 102861287 B CN102861287 B CN 102861287B CN 201210310306 A CN201210310306 A CN 201210310306A CN 102861287 B CN102861287 B CN 102861287B
- Authority
- CN
- China
- Prior art keywords
- parts
- blood
- heat
- chinese medicine
- preparation
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 210000004369 blood Anatomy 0.000 title claims abstract description 199
- 239000008280 blood Substances 0.000 title claims abstract description 199
- 239000000203 mixture Substances 0.000 title claims abstract description 41
- 208000008960 Diabetic foot Diseases 0.000 title claims abstract description 38
- 238000002360 preparation method Methods 0.000 title claims description 38
- 230000009545 invasion Effects 0.000 title 1
- 239000003814 drug Substances 0.000 claims abstract description 144
- 229940079593 drug Drugs 0.000 claims abstract description 45
- 239000007924 injection Substances 0.000 claims abstract description 29
- 238000002347 injection Methods 0.000 claims abstract description 29
- 244000020518 Carthamus tinctorius Species 0.000 claims abstract description 27
- 235000003255 Carthamus tinctorius Nutrition 0.000 claims abstract description 27
- 235000009411 Rheum rhabarbarum Nutrition 0.000 claims abstract description 24
- 229910052602 gypsum Inorganic materials 0.000 claims abstract description 20
- 239000010440 gypsum Substances 0.000 claims abstract description 20
- 241000218158 Clematis Species 0.000 claims abstract description 19
- 235000001287 Guettarda speciosa Nutrition 0.000 claims abstract description 16
- 241000605447 Anemarrhena Species 0.000 claims abstract description 15
- 244000061520 Angelica archangelica Species 0.000 claims abstract description 15
- 229930191283 anemarrhena Natural products 0.000 claims abstract description 15
- 241001061264 Astragalus Species 0.000 claims abstract description 14
- 241001313857 Bletilla striata Species 0.000 claims abstract description 14
- 241001071795 Gentiana Species 0.000 claims abstract description 14
- 235000003332 Ilex aquifolium Nutrition 0.000 claims abstract description 14
- 235000002296 Ilex sandwicensis Nutrition 0.000 claims abstract description 14
- 235000002294 Ilex volkensiana Nutrition 0.000 claims abstract description 14
- 235000006484 Paeonia officinalis Nutrition 0.000 claims abstract description 14
- 244000197580 Poria cocos Species 0.000 claims abstract description 14
- 235000008599 Poria cocos Nutrition 0.000 claims abstract description 14
- 235000006040 Prunus persica var persica Nutrition 0.000 claims abstract description 14
- 235000006533 astragalus Nutrition 0.000 claims abstract description 14
- 210000004233 talus Anatomy 0.000 claims abstract description 14
- 244000144730 Amygdalus persica Species 0.000 claims abstract description 13
- 241000092665 Atractylodes macrocephala Species 0.000 claims abstract description 13
- 235000003717 Boswellia sacra Nutrition 0.000 claims abstract description 13
- 240000007551 Boswellia serrata Species 0.000 claims abstract description 13
- 235000012035 Boswellia serrata Nutrition 0.000 claims abstract description 13
- 239000004863 Frankincense Substances 0.000 claims abstract description 13
- 235000019109 Patrinia villosa Nutrition 0.000 claims abstract description 13
- 235000011135 Salvia miltiorrhiza Nutrition 0.000 claims abstract description 13
- 241000913745 Spatholobus Species 0.000 claims abstract description 13
- 241000972672 Phellodendron Species 0.000 claims abstract description 12
- 235000005865 Symphytum officinale Nutrition 0.000 claims abstract description 12
- 240000007311 Commiphora myrrha Species 0.000 claims abstract description 11
- 235000006965 Commiphora myrrha Nutrition 0.000 claims abstract description 11
- 235000014375 Curcuma Nutrition 0.000 claims abstract description 11
- 235000007265 Myrrhis odorata Nutrition 0.000 claims abstract description 11
- VFLDPWHFBUODDF-FCXRPNKRSA-N curcumin Chemical compound C1=C(O)C(OC)=CC(\C=C\C(=O)CC(=O)\C=C\C=2C=C(OC)C(O)=CC=2)=C1 VFLDPWHFBUODDF-FCXRPNKRSA-N 0.000 claims abstract description 11
- 244000164480 Curcuma aromatica Species 0.000 claims abstract description 8
- 244000134552 Plantago ovata Species 0.000 claims abstract description 6
- 235000003421 Plantago ovata Nutrition 0.000 claims abstract description 6
- 239000009223 Psyllium Substances 0.000 claims abstract description 6
- 229940070687 psyllium Drugs 0.000 claims abstract description 6
- 240000002299 Symphytum officinale Species 0.000 claims abstract description 5
- 241000205585 Aquilegia canadensis Species 0.000 claims abstract 8
- 244000170916 Paeonia officinalis Species 0.000 claims abstract 4
- 244000148137 Patrinia villosa Species 0.000 claims abstract 4
- 244000299790 Rheum rhabarbarum Species 0.000 claims abstract 4
- 241000304195 Salvia miltiorrhiza Species 0.000 claims abstract 4
- 239000000843 powder Substances 0.000 claims description 68
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 59
- 238000011282 treatment Methods 0.000 claims description 51
- 210000002683 foot Anatomy 0.000 claims description 30
- 239000000284 extract Substances 0.000 claims description 18
- 239000002994 raw material Substances 0.000 claims description 15
- 239000007788 liquid Substances 0.000 claims description 14
- 239000012141 concentrate Substances 0.000 claims description 12
- 239000002552 dosage form Substances 0.000 claims description 11
- 238000000605 extraction Methods 0.000 claims description 10
- 239000000706 filtrate Substances 0.000 claims description 10
- 239000000243 solution Substances 0.000 claims description 10
- 239000002775 capsule Substances 0.000 claims description 9
- 239000002674 ointment Substances 0.000 claims description 8
- 235000003805 Musa ABB Group Nutrition 0.000 claims description 6
- 235000015266 Plantago major Nutrition 0.000 claims description 6
- 239000000463 material Substances 0.000 claims description 6
- 229940099259 vaseline Drugs 0.000 claims description 6
- 239000006187 pill Substances 0.000 claims description 5
- 210000000582 semen Anatomy 0.000 claims description 5
- 239000008187 granular material Substances 0.000 claims description 4
- 238000004659 sterilization and disinfection Methods 0.000 claims description 4
- 239000002253 acid Substances 0.000 claims description 3
- 239000003513 alkali Substances 0.000 claims description 3
- 239000007799 cork Substances 0.000 claims description 3
- 239000000469 ethanolic extract Substances 0.000 claims description 3
- 238000000926 separation method Methods 0.000 claims description 3
- -1 buccal preparations Substances 0.000 claims description 2
- 239000007902 hard capsule Substances 0.000 claims description 2
- 238000005470 impregnation Methods 0.000 claims description 2
- 239000007901 soft capsule Substances 0.000 claims description 2
- 239000007921 spray Substances 0.000 claims description 2
- 230000001954 sterilising effect Effects 0.000 claims description 2
- 239000003826 tablet Substances 0.000 claims description 2
- 229940098465 tincture Drugs 0.000 claims description 2
- 240000008790 Musa x paradisiaca Species 0.000 claims 2
- 239000007941 film coated tablet Substances 0.000 claims 1
- 239000006186 oral dosage form Substances 0.000 claims 1
- 230000017531 blood circulation Effects 0.000 abstract description 54
- 208000025865 Ulcer Diseases 0.000 abstract description 25
- 210000003141 lower extremity Anatomy 0.000 abstract description 23
- 231100000397 ulcer Toxicity 0.000 abstract description 22
- 210000003414 extremity Anatomy 0.000 abstract description 19
- 210000001519 tissue Anatomy 0.000 abstract description 19
- 230000029663 wound healing Effects 0.000 abstract description 16
- 238000005469 granulation Methods 0.000 abstract description 13
- 230000003179 granulation Effects 0.000 abstract description 13
- 230000001338 necrotic effect Effects 0.000 abstract description 13
- 231100000862 numbness Toxicity 0.000 abstract description 12
- 239000011248 coating agent Substances 0.000 abstract description 9
- 238000000576 coating method Methods 0.000 abstract description 9
- 230000004089 microcirculation Effects 0.000 abstract description 9
- 241000361919 Metaphire sieboldi Species 0.000 abstract description 8
- 206010008479 Chest Pain Diseases 0.000 abstract description 7
- 230000036772 blood pressure Effects 0.000 abstract description 6
- 230000036737 immune function Effects 0.000 abstract description 5
- 230000017423 tissue regeneration Effects 0.000 abstract description 5
- 206010024774 Localised infection Diseases 0.000 abstract description 4
- 208000015669 capillary disease Diseases 0.000 abstract description 4
- 241000209035 Ilex Species 0.000 abstract 1
- 235000014676 Phragmites communis Nutrition 0.000 abstract 1
- 230000036407 pain Effects 0.000 description 74
- 208000002193 Pain Diseases 0.000 description 73
- 208000027418 Wounds and injury Diseases 0.000 description 56
- 206010052428 Wound Diseases 0.000 description 51
- 230000001737 promoting effect Effects 0.000 description 42
- 230000000694 effects Effects 0.000 description 33
- 230000007812 deficiency Effects 0.000 description 25
- 210000004185 liver Anatomy 0.000 description 25
- 206010012601 diabetes mellitus Diseases 0.000 description 24
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 24
- 206010042674 Swelling Diseases 0.000 description 23
- 230000008961 swelling Effects 0.000 description 23
- 201000010099 disease Diseases 0.000 description 22
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 22
- 241001570521 Lonicera periclymenum Species 0.000 description 20
- 241000219061 Rheum Species 0.000 description 20
- 230000006870 function Effects 0.000 description 20
- 206010007247 Carbuncle Diseases 0.000 description 18
- 239000002398 materia medica Substances 0.000 description 17
- 210000004204 blood vessel Anatomy 0.000 description 16
- 208000032843 Hemorrhage Diseases 0.000 description 15
- 230000006378 damage Effects 0.000 description 15
- 206010017711 Gangrene Diseases 0.000 description 14
- 208000034158 bleeding Diseases 0.000 description 14
- 230000000740 bleeding effect Effects 0.000 description 14
- 208000034783 hypoesthesia Diseases 0.000 description 14
- 231100000614 poison Toxicity 0.000 description 14
- 208000011580 syndromic disease Diseases 0.000 description 14
- 206010012735 Diarrhoea Diseases 0.000 description 13
- 210000001015 abdomen Anatomy 0.000 description 13
- 210000002216 heart Anatomy 0.000 description 13
- 244000132619 red sage Species 0.000 description 13
- 210000000952 spleen Anatomy 0.000 description 13
- 206010062717 Increased upper airway secretion Diseases 0.000 description 12
- 241000700159 Rattus Species 0.000 description 12
- 230000015271 coagulation Effects 0.000 description 12
- 238000005345 coagulation Methods 0.000 description 12
- 208000001848 dysentery Diseases 0.000 description 12
- 238000000034 method Methods 0.000 description 12
- 208000026435 phlegm Diseases 0.000 description 12
- 208000004044 Hypesthesia Diseases 0.000 description 11
- 210000000988 bone and bone Anatomy 0.000 description 11
- 235000009508 confectionery Nutrition 0.000 description 11
- 230000035876 healing Effects 0.000 description 11
- 210000003734 kidney Anatomy 0.000 description 11
- 201000000736 Amenorrhea Diseases 0.000 description 10
- 206010001928 Amenorrhoea Diseases 0.000 description 10
- 208000006820 Arthralgia Diseases 0.000 description 10
- 206010011224 Cough Diseases 0.000 description 10
- 241000736199 Paeonia Species 0.000 description 10
- 231100000540 amenorrhea Toxicity 0.000 description 10
- 210000002784 stomach Anatomy 0.000 description 10
- 208000024891 symptom Diseases 0.000 description 10
- 206010010774 Constipation Diseases 0.000 description 9
- 241000606264 Patrinia Species 0.000 description 9
- 208000003251 Pruritus Diseases 0.000 description 9
- 238000002474 experimental method Methods 0.000 description 9
- 208000015181 infectious disease Diseases 0.000 description 9
- 230000002401 inhibitory effect Effects 0.000 description 9
- 210000004072 lung Anatomy 0.000 description 9
- 235000019640 taste Nutrition 0.000 description 9
- 239000003053 toxin Substances 0.000 description 9
- 201000004624 Dermatitis Diseases 0.000 description 8
- 206010030113 Oedema Diseases 0.000 description 8
- 230000002159 abnormal effect Effects 0.000 description 8
- 238000001816 cooling Methods 0.000 description 8
- 239000012530 fluid Substances 0.000 description 8
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 8
- 230000007803 itching Effects 0.000 description 8
- 231100000765 toxin Toxicity 0.000 description 8
- 108700012359 toxins Proteins 0.000 description 8
- 208000004998 Abdominal Pain Diseases 0.000 description 7
- 208000004880 Polyuria Diseases 0.000 description 7
- 241001442052 Symphytum Species 0.000 description 7
- 208000010668 atopic eczema Diseases 0.000 description 7
- 230000002951 depilatory effect Effects 0.000 description 7
- 238000001802 infusion Methods 0.000 description 7
- 239000010410 layer Substances 0.000 description 7
- 239000002574 poison Substances 0.000 description 7
- 230000008929 regeneration Effects 0.000 description 7
- 238000011069 regeneration method Methods 0.000 description 7
- 210000002435 tendon Anatomy 0.000 description 7
- 230000035922 thirst Effects 0.000 description 7
- 241000700198 Cavia Species 0.000 description 6
- 208000005171 Dysmenorrhea Diseases 0.000 description 6
- 206010013935 Dysmenorrhoea Diseases 0.000 description 6
- 208000037093 Menstruation Disturbances Diseases 0.000 description 6
- 206010027339 Menstruation irregular Diseases 0.000 description 6
- 241001465754 Metazoa Species 0.000 description 6
- UILPJVPSNHJFIK-UHFFFAOYSA-N Paeonol Chemical compound COC1=CC=C(C(C)=O)C(O)=C1 UILPJVPSNHJFIK-UHFFFAOYSA-N 0.000 description 6
- 241000246044 Sophora flavescens Species 0.000 description 6
- 208000033809 Suppuration Diseases 0.000 description 6
- 208000031975 Yang Deficiency Diseases 0.000 description 6
- 238000009825 accumulation Methods 0.000 description 6
- 230000035619 diuresis Effects 0.000 description 6
- 210000003743 erythrocyte Anatomy 0.000 description 6
- 235000013305 food Nutrition 0.000 description 6
- 208000014674 injury Diseases 0.000 description 6
- 230000037257 muscle growth Effects 0.000 description 6
- 210000003371 toe Anatomy 0.000 description 6
- 210000002700 urine Anatomy 0.000 description 6
- 210000001835 viscera Anatomy 0.000 description 6
- 208000034656 Contusions Diseases 0.000 description 5
- 206010010904 Convulsion Diseases 0.000 description 5
- 208000015220 Febrile disease Diseases 0.000 description 5
- 206010019233 Headaches Diseases 0.000 description 5
- 102000004877 Insulin Human genes 0.000 description 5
- 108090001061 Insulin Proteins 0.000 description 5
- 206010028851 Necrosis Diseases 0.000 description 5
- 206010033799 Paralysis Diseases 0.000 description 5
- 241001127637 Plantago Species 0.000 description 5
- 208000025747 Rheumatic disease Diseases 0.000 description 5
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 5
- 208000006011 Stroke Diseases 0.000 description 5
- 238000002266 amputation Methods 0.000 description 5
- 230000000844 anti-bacterial effect Effects 0.000 description 5
- 230000004596 appetite loss Effects 0.000 description 5
- 230000037396 body weight Effects 0.000 description 5
- 230000008859 change Effects 0.000 description 5
- 239000003795 chemical substances by application Substances 0.000 description 5
- 230000036461 convulsion Effects 0.000 description 5
- 208000002173 dizziness Diseases 0.000 description 5
- 231100000869 headache Toxicity 0.000 description 5
- 230000002439 hemostatic effect Effects 0.000 description 5
- 230000003902 lesion Effects 0.000 description 5
- 230000007774 longterm Effects 0.000 description 5
- 208000019017 loss of appetite Diseases 0.000 description 5
- 235000021266 loss of appetite Nutrition 0.000 description 5
- 210000003205 muscle Anatomy 0.000 description 5
- 230000017074 necrotic cell death Effects 0.000 description 5
- 210000005036 nerve Anatomy 0.000 description 5
- 231100000252 nontoxic Toxicity 0.000 description 5
- 230000003000 nontoxic effect Effects 0.000 description 5
- 230000000552 rheumatic effect Effects 0.000 description 5
- 238000012360 testing method Methods 0.000 description 5
- WTPPRJKFRFIQKT-UHFFFAOYSA-N 1,6-dimethyl-8,9-dihydronaphtho[1,2-g][1]benzofuran-10,11-dione;1-methyl-6-methylidene-8,9-dihydro-7h-naphtho[1,2-g][1]benzofuran-10,11-dione Chemical compound O=C1C(=O)C2=C3CCCC(=C)C3=CC=C2C2=C1C(C)=CO2.O=C1C(=O)C2=C3CCC=C(C)C3=CC=C2C2=C1C(C)=CO2 WTPPRJKFRFIQKT-UHFFFAOYSA-N 0.000 description 4
- 241000700199 Cavia porcellus Species 0.000 description 4
- 206010012665 Diabetic gangrene Diseases 0.000 description 4
- 206010063560 Excessive granulation tissue Diseases 0.000 description 4
- 102000009123 Fibrin Human genes 0.000 description 4
- 108010073385 Fibrin Proteins 0.000 description 4
- BWGVNKXGVNDBDI-UHFFFAOYSA-N Fibrin monomer Chemical compound CNC(=O)CNC(=O)CN BWGVNKXGVNDBDI-UHFFFAOYSA-N 0.000 description 4
- 206010019468 Hemiplegia Diseases 0.000 description 4
- 206010061218 Inflammation Diseases 0.000 description 4
- 241000249820 Lipotes vexillifer Species 0.000 description 4
- 208000007101 Muscle Cramp Diseases 0.000 description 4
- 206010033557 Palpitations Diseases 0.000 description 4
- 206010037660 Pyrexia Diseases 0.000 description 4
- 206010038743 Restlessness Diseases 0.000 description 4
- 208000005392 Spasm Diseases 0.000 description 4
- 206010053615 Thermal burn Diseases 0.000 description 4
- 208000031971 Yin Deficiency Diseases 0.000 description 4
- 239000002390 adhesive tape Substances 0.000 description 4
- 210000001367 artery Anatomy 0.000 description 4
- 208000006673 asthma Diseases 0.000 description 4
- 230000001914 calming effect Effects 0.000 description 4
- 230000004069 differentiation Effects 0.000 description 4
- 210000000981 epithelium Anatomy 0.000 description 4
- 229950003499 fibrin Drugs 0.000 description 4
- 210000001126 granulation tissue Anatomy 0.000 description 4
- 229940125396 insulin Drugs 0.000 description 4
- 210000000265 leukocyte Anatomy 0.000 description 4
- 210000000056 organ Anatomy 0.000 description 4
- 208000035824 paresthesia Diseases 0.000 description 4
- 230000008506 pathogenesis Effects 0.000 description 4
- 230000007096 poisonous effect Effects 0.000 description 4
- 208000010110 spontaneous platelet aggregation Diseases 0.000 description 4
- 230000035900 sweating Effects 0.000 description 4
- 210000003462 vein Anatomy 0.000 description 4
- 206010008190 Cerebrovascular accident Diseases 0.000 description 3
- 241000407170 Curcuma Species 0.000 description 3
- 201000000297 Erysipelas Diseases 0.000 description 3
- 206010015150 Erythema Diseases 0.000 description 3
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 3
- 208000000616 Hemoptysis Diseases 0.000 description 3
- 239000009636 Huang Qi Substances 0.000 description 3
- 206010022562 Intermittent claudication Diseases 0.000 description 3
- 241000245240 Lonicera Species 0.000 description 3
- 241000699670 Mus sp. Species 0.000 description 3
- 208000001431 Psychomotor Agitation Diseases 0.000 description 3
- 206010039509 Scab Diseases 0.000 description 3
- 239000008627 Shengji ointment Substances 0.000 description 3
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 3
- 241000191967 Staphylococcus aureus Species 0.000 description 3
- 206010041956 Stasis syndrome Diseases 0.000 description 3
- 208000007271 Substance Withdrawal Syndrome Diseases 0.000 description 3
- 208000007536 Thrombosis Diseases 0.000 description 3
- 206010053476 Traumatic haemorrhage Diseases 0.000 description 3
- 206010053648 Vascular occlusion Diseases 0.000 description 3
- 206010047700 Vomiting Diseases 0.000 description 3
- 238000010521 absorption reaction Methods 0.000 description 3
- 230000001154 acute effect Effects 0.000 description 3
- 230000003110 anti-inflammatory effect Effects 0.000 description 3
- 230000008901 benefit Effects 0.000 description 3
- 230000015572 biosynthetic process Effects 0.000 description 3
- 208000005634 blind loop syndrome Diseases 0.000 description 3
- 238000004820 blood count Methods 0.000 description 3
- 230000036770 blood supply Effects 0.000 description 3
- 208000029078 coronary artery disease Diseases 0.000 description 3
- 230000003247 decreasing effect Effects 0.000 description 3
- 238000001784 detoxification Methods 0.000 description 3
- 239000008103 glucose Substances 0.000 description 3
- 208000014617 hemorrhoid Diseases 0.000 description 3
- 230000001939 inductive effect Effects 0.000 description 3
- 230000004054 inflammatory process Effects 0.000 description 3
- 206010022437 insomnia Diseases 0.000 description 3
- 208000021156 intermittent vascular claudication Diseases 0.000 description 3
- 238000001990 intravenous administration Methods 0.000 description 3
- 208000028867 ischemia Diseases 0.000 description 3
- YLTGFGDODHXMFB-UHFFFAOYSA-N isoacetovanillon Natural products COC1=CC=C(C(C)=O)C=C1O YLTGFGDODHXMFB-UHFFFAOYSA-N 0.000 description 3
- 210000002429 large intestine Anatomy 0.000 description 3
- 201000007227 lymph node tuberculosis Diseases 0.000 description 3
- 230000014759 maintenance of location Effects 0.000 description 3
- 230000003211 malignant effect Effects 0.000 description 3
- 238000004519 manufacturing process Methods 0.000 description 3
- 230000002175 menstrual effect Effects 0.000 description 3
- 230000027939 micturition Effects 0.000 description 3
- 230000037311 normal skin Effects 0.000 description 3
- 239000003921 oil Substances 0.000 description 3
- 235000019198 oils Nutrition 0.000 description 3
- MLIBGOFSXXWRIY-UHFFFAOYSA-N paeonol Natural products COC1=CC=C(O)C(C(C)=O)=C1 MLIBGOFSXXWRIY-UHFFFAOYSA-N 0.000 description 3
- 231100000915 pathological change Toxicity 0.000 description 3
- 230000036285 pathological change Effects 0.000 description 3
- 230000001575 pathological effect Effects 0.000 description 3
- 230000010412 perfusion Effects 0.000 description 3
- 230000003285 pharmacodynamic effect Effects 0.000 description 3
- 230000000144 pharmacologic effect Effects 0.000 description 3
- 239000000047 product Substances 0.000 description 3
- 238000010926 purge Methods 0.000 description 3
- 230000002829 reductive effect Effects 0.000 description 3
- 230000001105 regulatory effect Effects 0.000 description 3
- 238000011160 research Methods 0.000 description 3
- 239000011347 resin Substances 0.000 description 3
- 229920005989 resin Polymers 0.000 description 3
- 230000028327 secretion Effects 0.000 description 3
- 239000013589 supplement Substances 0.000 description 3
- 210000002465 tibial artery Anatomy 0.000 description 3
- 210000004906 toe nail Anatomy 0.000 description 3
- 230000001256 tonic effect Effects 0.000 description 3
- 206010044008 tonsillitis Diseases 0.000 description 3
- 231100000331 toxic Toxicity 0.000 description 3
- 230000002588 toxic effect Effects 0.000 description 3
- 239000003440 toxic substance Substances 0.000 description 3
- 208000021331 vascular occlusion disease Diseases 0.000 description 3
- 230000008673 vomiting Effects 0.000 description 3
- UPXRTVAIJMUAQR-UHFFFAOYSA-N 4-(9h-fluoren-9-ylmethoxycarbonylamino)-1-[(2-methylpropan-2-yl)oxycarbonyl]pyrrolidine-2-carboxylic acid Chemical compound C1C(C(O)=O)N(C(=O)OC(C)(C)C)CC1NC(=O)OCC1C2=CC=CC=C2C2=CC=CC=C21 UPXRTVAIJMUAQR-UHFFFAOYSA-N 0.000 description 2
- QTQGHKVYLQBJLO-UHFFFAOYSA-N 4-methylbenzenesulfonate;(4-methyl-1-oxo-1-phenylmethoxypentan-2-yl)azanium Chemical compound CC1=CC=C(S(O)(=O)=O)C=C1.CC(C)CC(N)C(=O)OCC1=CC=CC=C1 QTQGHKVYLQBJLO-UHFFFAOYSA-N 0.000 description 2
- 206010000060 Abdominal distension Diseases 0.000 description 2
- 206010063409 Acarodermatitis Diseases 0.000 description 2
- 206010003011 Appendicitis Diseases 0.000 description 2
- 244000063299 Bacillus subtilis Species 0.000 description 2
- 235000014469 Bacillus subtilis Nutrition 0.000 description 2
- 208000033386 Buerger disease Diseases 0.000 description 2
- 206010006797 Burns first degree Diseases 0.000 description 2
- 206010006802 Burns second degree Diseases 0.000 description 2
- 244000025254 Cannabis sativa Species 0.000 description 2
- 235000003405 Curcuma zedoaria Nutrition 0.000 description 2
- 240000009138 Curcuma zedoaria Species 0.000 description 2
- 208000004232 Enteritis Diseases 0.000 description 2
- 208000010201 Exanthema Diseases 0.000 description 2
- 206010059385 Extremity necrosis Diseases 0.000 description 2
- 208000003790 Foot Ulcer Diseases 0.000 description 2
- 206010017553 Furuncle Diseases 0.000 description 2
- CEAZRRDELHUEMR-URQXQFDESA-N Gentamicin Chemical compound O1[C@H](C(C)NC)CC[C@@H](N)[C@H]1O[C@H]1[C@H](O)[C@@H](O[C@@H]2[C@@H]([C@@H](NC)[C@@](C)(O)CO2)O)[C@H](N)C[C@@H]1N CEAZRRDELHUEMR-URQXQFDESA-N 0.000 description 2
- 229930182566 Gentamicin Natural products 0.000 description 2
- 208000034507 Haematemesis Diseases 0.000 description 2
- 206010018873 Haemoconcentration Diseases 0.000 description 2
- 241000282414 Homo sapiens Species 0.000 description 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 2
- MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 description 2
- 206010020565 Hyperaemia Diseases 0.000 description 2
- 206010021118 Hypotonia Diseases 0.000 description 2
- 206010023126 Jaundice Diseases 0.000 description 2
- 206010023379 Ketoacidosis Diseases 0.000 description 2
- 208000007976 Ketosis Diseases 0.000 description 2
- 208000002720 Malnutrition Diseases 0.000 description 2
- 201000005505 Measles Diseases 0.000 description 2
- 206010027514 Metrorrhagia Diseases 0.000 description 2
- 241001480037 Microsporum Species 0.000 description 2
- 241000244206 Nematoda Species 0.000 description 2
- 206010028980 Neoplasm Diseases 0.000 description 2
- RXUWDKBZZLIASQ-UHFFFAOYSA-N Puerarin Natural products OCC1OC(Oc2c(O)cc(O)c3C(=O)C(=COc23)c4ccc(O)cc4)C(O)C(O)C1O RXUWDKBZZLIASQ-UHFFFAOYSA-N 0.000 description 2
- 206010038910 Retinitis Diseases 0.000 description 2
- 241000447727 Scabies Species 0.000 description 2
- 241000191940 Staphylococcus Species 0.000 description 2
- AIGAZQPHXLWMOJ-UHFFFAOYSA-N Tanshinone I Chemical compound C1=CC2=C(C)C=CC=C2C(C(=O)C2=O)=C1C1=C2C(C)=CO1 AIGAZQPHXLWMOJ-UHFFFAOYSA-N 0.000 description 2
- 206010043540 Thromboangiitis obliterans Diseases 0.000 description 2
- 206010047571 Visual impairment Diseases 0.000 description 2
- 206010047601 Vitamin B1 deficiency Diseases 0.000 description 2
- UCTWMZQNUQWSLP-UHFFFAOYSA-N adrenaline Chemical compound CNCC(O)C1=CC=C(O)C(O)=C1 UCTWMZQNUQWSLP-UHFFFAOYSA-N 0.000 description 2
- PYKYMHQGRFAEBM-UHFFFAOYSA-N anthraquinone Natural products CCC(=O)c1c(O)c2C(=O)C3C(C=CC=C3O)C(=O)c2cc1CC(=O)OC PYKYMHQGRFAEBM-UHFFFAOYSA-N 0.000 description 2
- 150000004056 anthraquinones Chemical class 0.000 description 2
- 239000003242 anti bacterial agent Substances 0.000 description 2
- 229940088710 antibiotic agent Drugs 0.000 description 2
- 230000009286 beneficial effect Effects 0.000 description 2
- FCPVYOBCFFNJFS-LQDWTQKMSA-M benzylpenicillin sodium Chemical compound [Na+].N([C@H]1[C@H]2SC([C@@H](N2C1=O)C([O-])=O)(C)C)C(=O)CC1=CC=CC=C1 FCPVYOBCFFNJFS-LQDWTQKMSA-M 0.000 description 2
- 208000002894 beriberi Diseases 0.000 description 2
- 210000000601 blood cell Anatomy 0.000 description 2
- 230000023555 blood coagulation Effects 0.000 description 2
- 210000001124 body fluid Anatomy 0.000 description 2
- 239000010839 body fluid Substances 0.000 description 2
- 210000004556 brain Anatomy 0.000 description 2
- 235000021152 breakfast Nutrition 0.000 description 2
- 208000026106 cerebrovascular disease Diseases 0.000 description 2
- 239000001812 curcuma zedoaria berg. rosc. Substances 0.000 description 2
- 238000001804 debridement Methods 0.000 description 2
- 230000007547 defect Effects 0.000 description 2
- 230000002950 deficient Effects 0.000 description 2
- 230000000779 depleting effect Effects 0.000 description 2
- 238000003745 diagnosis Methods 0.000 description 2
- 235000005911 diet Nutrition 0.000 description 2
- 230000037213 diet Effects 0.000 description 2
- 239000002934 diuretic Substances 0.000 description 2
- 230000001882 diuretic effect Effects 0.000 description 2
- 238000001035 drying Methods 0.000 description 2
- 206010013990 dysuria Diseases 0.000 description 2
- 206010015037 epilepsy Diseases 0.000 description 2
- 208000001780 epistaxis Diseases 0.000 description 2
- 231100000321 erythema Toxicity 0.000 description 2
- 230000003203 everyday effect Effects 0.000 description 2
- 201000005884 exanthem Diseases 0.000 description 2
- 230000004438 eyesight Effects 0.000 description 2
- 206010016256 fatigue Diseases 0.000 description 2
- 230000001605 fetal effect Effects 0.000 description 2
- 208000017561 flaccidity Diseases 0.000 description 2
- 239000000796 flavoring agent Substances 0.000 description 2
- 235000019634 flavors Nutrition 0.000 description 2
- 230000037406 food intake Effects 0.000 description 2
- 235000012631 food intake Nutrition 0.000 description 2
- 210000000232 gallbladder Anatomy 0.000 description 2
- 230000002496 gastric effect Effects 0.000 description 2
- 229960002518 gentamicin Drugs 0.000 description 2
- 230000037308 hair color Effects 0.000 description 2
- 238000010438 heat treatment Methods 0.000 description 2
- 208000006750 hematuria Diseases 0.000 description 2
- 208000021760 high fever Diseases 0.000 description 2
- 229960001401 hydrocortisone sodium succinate Drugs 0.000 description 2
- 230000002218 hypoglycaemic effect Effects 0.000 description 2
- 230000001976 improved effect Effects 0.000 description 2
- 230000002757 inflammatory effect Effects 0.000 description 2
- PBGKTOXHQIOBKM-FHFVDXKLSA-N insulin (human) Chemical compound C([C@@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@H]1CSSC[C@H]2C(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)N[C@H](C(=O)N[C@H](C(N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC=3C=CC(O)=CC=3)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC=3C=CC(O)=CC=3)C(=O)N[C@@H](CSSC[C@H](NC(=O)[C@H](C(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC=3C=CC(O)=CC=3)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](C(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC=3NC=NC=3)NC(=O)[C@H](CO)NC(=O)CNC1=O)C(=O)NCC(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)NCC(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(O)=O)C(=O)N[C@@H](CC(N)=O)C(O)=O)=O)CSSC[C@@H](C(N2)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](C(C)C)NC(=O)[C@@H](NC(=O)CN)[C@@H](C)CC)[C@@H](C)CC)[C@@H](C)O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](NC(=O)[C@@H](N)CC=1C=CC=CC=1)C(C)C)C1=CN=CN1 PBGKTOXHQIOBKM-FHFVDXKLSA-N 0.000 description 2
- 230000000968 intestinal effect Effects 0.000 description 2
- 239000007928 intraperitoneal injection Substances 0.000 description 2
- 229960004184 ketamine hydrochloride Drugs 0.000 description 2
- 210000002414 leg Anatomy 0.000 description 2
- 201000004792 malaria Diseases 0.000 description 2
- 235000000824 malnutrition Nutrition 0.000 description 2
- 230000001071 malnutrition Effects 0.000 description 2
- 230000007246 mechanism Effects 0.000 description 2
- 230000007721 medicinal effect Effects 0.000 description 2
- 230000005906 menstruation Effects 0.000 description 2
- 229910052751 metal Inorganic materials 0.000 description 2
- 239000002184 metal Substances 0.000 description 2
- 235000013336 milk Nutrition 0.000 description 2
- 239000008267 milk Substances 0.000 description 2
- 210000004080 milk Anatomy 0.000 description 2
- 210000002569 neuron Anatomy 0.000 description 2
- 201000001119 neuropathy Diseases 0.000 description 2
- 230000007823 neuropathy Effects 0.000 description 2
- 210000000440 neutrophil Anatomy 0.000 description 2
- 230000036565 night sweats Effects 0.000 description 2
- 206010029410 night sweats Diseases 0.000 description 2
- IAIWVQXQOWNYOU-FPYGCLRLSA-N nitrofural Chemical compound NC(=O)N\N=C\C1=CC=C([N+]([O-])=O)O1 IAIWVQXQOWNYOU-FPYGCLRLSA-N 0.000 description 2
- 229960001907 nitrofurazone Drugs 0.000 description 2
- 235000016709 nutrition Nutrition 0.000 description 2
- 230000035764 nutrition Effects 0.000 description 2
- 208000030212 nutrition disease Diseases 0.000 description 2
- 208000015380 nutritional deficiency disease Diseases 0.000 description 2
- 208000019180 nutritional disease Diseases 0.000 description 2
- 244000045947 parasite Species 0.000 description 2
- 208000033808 peripheral neuropathy Diseases 0.000 description 2
- 235000019271 petrolatum Nutrition 0.000 description 2
- 206010036067 polydipsia Diseases 0.000 description 2
- 230000001681 protective effect Effects 0.000 description 2
- HKEAFJYKMMKDOR-VPRICQMDSA-N puerarin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1C1=C(O)C=CC(C2=O)=C1OC=C2C1=CC=C(O)C=C1 HKEAFJYKMMKDOR-VPRICQMDSA-N 0.000 description 2
- 238000010791 quenching Methods 0.000 description 2
- 230000000171 quenching effect Effects 0.000 description 2
- 206010037844 rash Diseases 0.000 description 2
- 229910052957 realgar Inorganic materials 0.000 description 2
- 230000002040 relaxant effect Effects 0.000 description 2
- 230000000284 resting effect Effects 0.000 description 2
- 238000000518 rheometry Methods 0.000 description 2
- 208000005687 scabies Diseases 0.000 description 2
- 238000004062 sedimentation Methods 0.000 description 2
- 230000037380 skin damage Effects 0.000 description 2
- 239000002904 solvent Substances 0.000 description 2
- 235000015096 spirit Nutrition 0.000 description 2
- 230000002269 spontaneous effect Effects 0.000 description 2
- 238000010025 steaming Methods 0.000 description 2
- 238000001356 surgical procedure Methods 0.000 description 2
- 229920001864 tannin Polymers 0.000 description 2
- 235000018553 tannin Nutrition 0.000 description 2
- 239000001648 tannin Substances 0.000 description 2
- 230000032258 transport Effects 0.000 description 2
- 238000009966 trimming Methods 0.000 description 2
- 230000036269 ulceration Effects 0.000 description 2
- 210000003932 urinary bladder Anatomy 0.000 description 2
- 208000029257 vision disease Diseases 0.000 description 2
- 230000004393 visual impairment Effects 0.000 description 2
- 238000010792 warming Methods 0.000 description 2
- 235000019509 white turmeric Nutrition 0.000 description 2
- SFLSHLFXELFNJZ-QMMMGPOBSA-N (-)-norepinephrine Chemical compound NC[C@H](O)C1=CC=C(O)C(O)=C1 SFLSHLFXELFNJZ-QMMMGPOBSA-N 0.000 description 1
- ONDRRTIAGBDDKP-PPHPATTJSA-N 294662-18-3 Chemical compound CC(O)C(O)=O.C([C@@H](N1C2=C(C(C(C(O)=O)=C1)=O)C=C1F)C)OC2=C1N1CCN(C)CC1 ONDRRTIAGBDDKP-PPHPATTJSA-N 0.000 description 1
- 206010000077 Abdominal mass Diseases 0.000 description 1
- 208000019901 Anxiety disease Diseases 0.000 description 1
- 206010003210 Arteriosclerosis Diseases 0.000 description 1
- 201000001320 Atherosclerosis Diseases 0.000 description 1
- 241000193830 Bacillus <bacterium> Species 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- 206010006326 Breath odour Diseases 0.000 description 1
- 108010074051 C-Reactive Protein Proteins 0.000 description 1
- 102100032752 C-reactive protein Human genes 0.000 description 1
- 241000345998 Calamus manan Species 0.000 description 1
- 102000055006 Calcitonin Human genes 0.000 description 1
- 108060001064 Calcitonin Proteins 0.000 description 1
- 206010006956 Calcium deficiency Diseases 0.000 description 1
- 241000222122 Candida albicans Species 0.000 description 1
- 241000282472 Canis lupus familiaris Species 0.000 description 1
- 208000024172 Cardiovascular disease Diseases 0.000 description 1
- 208000010445 Chilblains Diseases 0.000 description 1
- 208000013017 Child Nutrition disease Diseases 0.000 description 1
- 206010008528 Chillblains Diseases 0.000 description 1
- 208000032544 Cicatrix Diseases 0.000 description 1
- 206010069729 Collateral circulation Diseases 0.000 description 1
- 208000035473 Communicable disease Diseases 0.000 description 1
- 206010010741 Conjunctivitis Diseases 0.000 description 1
- 241000037740 Coptis chinensis Species 0.000 description 1
- 229920000742 Cotton Polymers 0.000 description 1
- 102000004127 Cytokines Human genes 0.000 description 1
- 108090000695 Cytokines Proteins 0.000 description 1
- 206010011878 Deafness Diseases 0.000 description 1
- 206010012218 Delirium Diseases 0.000 description 1
- 206010012335 Dependence Diseases 0.000 description 1
- 208000007342 Diabetic Nephropathies Diseases 0.000 description 1
- 208000032131 Diabetic Neuropathies Diseases 0.000 description 1
- 206010049927 Dry gangrene Diseases 0.000 description 1
- 206010013832 Duodenal perforation Diseases 0.000 description 1
- 208000030814 Eating disease Diseases 0.000 description 1
- 208000005189 Embolism Diseases 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 240000001624 Espostoa lanata Species 0.000 description 1
- 235000009161 Espostoa lanata Nutrition 0.000 description 1
- 206010015958 Eye pain Diseases 0.000 description 1
- 208000019454 Feeding and Eating disease Diseases 0.000 description 1
- 108010088842 Fibrinolysin Proteins 0.000 description 1
- 208000014770 Foot disease Diseases 0.000 description 1
- 241000233866 Fungi Species 0.000 description 1
- 206010017815 Gastric perforation Diseases 0.000 description 1
- 208000012671 Gastrointestinal haemorrhages Diseases 0.000 description 1
- 241001135871 Gentiana scabra Species 0.000 description 1
- 206010018286 Gingival pain Diseases 0.000 description 1
- 206010018291 Gingival swelling Diseases 0.000 description 1
- 102000017011 Glycated Hemoglobin A Human genes 0.000 description 1
- 201000005569 Gout Diseases 0.000 description 1
- 240000002045 Guettarda speciosa Species 0.000 description 1
- 208000037319 Hepatitis infectious Diseases 0.000 description 1
- 206010019909 Hernia Diseases 0.000 description 1
- 241000238631 Hexapoda Species 0.000 description 1
- 101000976075 Homo sapiens Insulin Proteins 0.000 description 1
- 208000033830 Hot Flashes Diseases 0.000 description 1
- 206010060800 Hot flush Diseases 0.000 description 1
- 206010020751 Hypersensitivity Diseases 0.000 description 1
- 206010020772 Hypertension Diseases 0.000 description 1
- 208000003623 Hypoalbuminemia Diseases 0.000 description 1
- 206010061245 Internal injury Diseases 0.000 description 1
- 206010065611 Intestinal congestion Diseases 0.000 description 1
- 206010022998 Irritability Diseases 0.000 description 1
- 208000009481 Laryngeal Edema Diseases 0.000 description 1
- 206010023845 Laryngeal oedema Diseases 0.000 description 1
- 206010024229 Leprosy Diseases 0.000 description 1
- 241000244365 Ligusticum sinense Species 0.000 description 1
- 206010025421 Macule Diseases 0.000 description 1
- 206010026749 Mania Diseases 0.000 description 1
- 208000005647 Mumps Diseases 0.000 description 1
- 244000132436 Myrica rubra Species 0.000 description 1
- 241001057584 Myrrha Species 0.000 description 1
- 206010028813 Nausea Diseases 0.000 description 1
- 206010028836 Neck pain Diseases 0.000 description 1
- 206010059013 Nocturnal emission Diseases 0.000 description 1
- 206010030302 Oliguria Diseases 0.000 description 1
- 206010068319 Oropharyngeal pain Diseases 0.000 description 1
- 208000000114 Pain Threshold Diseases 0.000 description 1
- 206010033425 Pain in extremity Diseases 0.000 description 1
- 240000004371 Panax ginseng Species 0.000 description 1
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 description 1
- 235000003140 Panax quinquefolius Nutrition 0.000 description 1
- 208000037273 Pathologic Processes Diseases 0.000 description 1
- 206010034568 Peripheral coldness Diseases 0.000 description 1
- 201000007100 Pharyngitis Diseases 0.000 description 1
- 241000283966 Pholidota <mammal> Species 0.000 description 1
- 208000005374 Poisoning Diseases 0.000 description 1
- 208000018525 Postpartum Hemorrhage Diseases 0.000 description 1
- 102000007327 Protamines Human genes 0.000 description 1
- 108010007568 Protamines Proteins 0.000 description 1
- 102100027378 Prothrombin Human genes 0.000 description 1
- 108010094028 Prothrombin Proteins 0.000 description 1
- 240000005809 Prunus persica Species 0.000 description 1
- 208000032536 Pseudomonas Infections Diseases 0.000 description 1
- 241000589517 Pseudomonas aeruginosa Species 0.000 description 1
- 239000010075 Qingdai compound Substances 0.000 description 1
- 206010037884 Rash pruritic Diseases 0.000 description 1
- 206010057190 Respiratory tract infections Diseases 0.000 description 1
- 241000245165 Rhododendron ponticum Species 0.000 description 1
- 206010039424 Salivary hypersecretion Diseases 0.000 description 1
- 241000207929 Scutellaria Species 0.000 description 1
- 240000004534 Scutellaria baicalensis Species 0.000 description 1
- 235000017089 Scutellaria baicalensis Nutrition 0.000 description 1
- 241000242583 Scyphozoa Species 0.000 description 1
- 241000607764 Shigella dysenteriae Species 0.000 description 1
- 206010040849 Skin fissures Diseases 0.000 description 1
- 208000032140 Sleepiness Diseases 0.000 description 1
- 208000004078 Snake Bites Diseases 0.000 description 1
- 206010041349 Somnolence Diseases 0.000 description 1
- 206010041497 Spermatorrhoea Diseases 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- 241000194017 Streptococcus Species 0.000 description 1
- 229930183118 Tanshinone Natural products 0.000 description 1
- 206010043376 Tetanus Diseases 0.000 description 1
- 208000002474 Tinea Diseases 0.000 description 1
- 241000223238 Trichophyton Species 0.000 description 1
- 241000893966 Trichophyton verrucosum Species 0.000 description 1
- 206010046306 Upper respiratory tract infection Diseases 0.000 description 1
- 206010046555 Urinary retention Diseases 0.000 description 1
- 206010046851 Uveitis Diseases 0.000 description 1
- 206010046914 Vaginal infection Diseases 0.000 description 1
- 201000008100 Vaginitis Diseases 0.000 description 1
- 208000035868 Vascular inflammations Diseases 0.000 description 1
- 206010057469 Vascular stenosis Diseases 0.000 description 1
- 206010047115 Vasculitis Diseases 0.000 description 1
- 208000003085 Water-Electrolyte Imbalance Diseases 0.000 description 1
- 206010048038 Wound infection Diseases 0.000 description 1
- 206010053716 Wound necrosis Diseases 0.000 description 1
- 206010000269 abscess Diseases 0.000 description 1
- 239000002250 absorbent Substances 0.000 description 1
- 230000002745 absorbent Effects 0.000 description 1
- 230000003213 activating effect Effects 0.000 description 1
- 230000004913 activation Effects 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 206010000891 acute myocardial infarction Diseases 0.000 description 1
- 230000007059 acute toxicity Effects 0.000 description 1
- 231100000403 acute toxicity Toxicity 0.000 description 1
- 208000026935 allergic disease Diseases 0.000 description 1
- 230000007815 allergy Effects 0.000 description 1
- 230000036592 analgesia Effects 0.000 description 1
- 230000000202 analgesic effect Effects 0.000 description 1
- 230000001760 anti-analgesic effect Effects 0.000 description 1
- 230000000843 anti-fungal effect Effects 0.000 description 1
- 230000002924 anti-infective effect Effects 0.000 description 1
- 230000001166 anti-perspirative effect Effects 0.000 description 1
- 230000001754 anti-pyretic effect Effects 0.000 description 1
- 230000000840 anti-viral effect Effects 0.000 description 1
- 230000003457 anti-vomiting effect Effects 0.000 description 1
- 239000003472 antidiabetic agent Substances 0.000 description 1
- 239000003213 antiperspirant Substances 0.000 description 1
- 239000002221 antipyretic Substances 0.000 description 1
- 229940019336 antithrombotic enzyme Drugs 0.000 description 1
- 230000036506 anxiety Effects 0.000 description 1
- 230000036528 appetite Effects 0.000 description 1
- 235000019789 appetite Nutrition 0.000 description 1
- 208000011775 arteriosclerosis disease Diseases 0.000 description 1
- 235000019606 astringent taste Nutrition 0.000 description 1
- 210000000467 autonomic pathway Anatomy 0.000 description 1
- 210000001142 back Anatomy 0.000 description 1
- 230000001580 bacterial effect Effects 0.000 description 1
- 230000006399 behavior Effects 0.000 description 1
- 210000003445 biliary tract Anatomy 0.000 description 1
- 238000010876 biochemical test Methods 0.000 description 1
- 235000010290 biphenyl Nutrition 0.000 description 1
- 150000004074 biphenyls Chemical class 0.000 description 1
- 230000000903 blocking effect Effects 0.000 description 1
- 230000036760 body temperature Effects 0.000 description 1
- 230000001488 breeding effect Effects 0.000 description 1
- 210000000621 bronchi Anatomy 0.000 description 1
- 208000034526 bruise Diseases 0.000 description 1
- BBBFJLBPOGFECG-VJVYQDLKSA-N calcitonin Chemical compound N([C@H](C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC=1NC=NC=1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)NCC(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@@H]([C@@H](C)O)C(=O)N1[C@@H](CCC1)C(N)=O)C(C)C)C(=O)[C@@H]1CSSC[C@H](N)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H]([C@@H](C)O)C(=O)N1 BBBFJLBPOGFECG-VJVYQDLKSA-N 0.000 description 1
- 229960004015 calcitonin Drugs 0.000 description 1
- 229940095731 candida albicans Drugs 0.000 description 1
- 210000003756 cervix mucus Anatomy 0.000 description 1
- 208000003796 chancre Diseases 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 230000004087 circulation Effects 0.000 description 1
- 238000011109 contamination Methods 0.000 description 1
- 230000001276 controlling effect Effects 0.000 description 1
- 230000001186 cumulative effect Effects 0.000 description 1
- 238000007405 data analysis Methods 0.000 description 1
- 231100000895 deafness Toxicity 0.000 description 1
- 230000013872 defecation Effects 0.000 description 1
- 230000007123 defense Effects 0.000 description 1
- 239000008367 deionised water Substances 0.000 description 1
- 229910021641 deionized water Inorganic materials 0.000 description 1
- 230000003111 delayed effect Effects 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 229960003957 dexamethasone Drugs 0.000 description 1
- UREBDLICKHMUKA-CXSFZGCWSA-N dexamethasone Chemical compound C1CC2=CC(=O)C=C[C@]2(C)[C@]2(F)[C@@H]1[C@@H]1C[C@@H](C)[C@@](C(=O)CO)(O)[C@@]1(C)C[C@@H]2O UREBDLICKHMUKA-CXSFZGCWSA-N 0.000 description 1
- 208000033679 diabetic kidney disease Diseases 0.000 description 1
- 230000000916 dilatatory effect Effects 0.000 description 1
- 238000007598 dipping method Methods 0.000 description 1
- 230000008034 disappearance Effects 0.000 description 1
- 208000035475 disorder Diseases 0.000 description 1
- 235000014632 disordered eating Nutrition 0.000 description 1
- 239000012153 distilled water Substances 0.000 description 1
- 208000017574 dry cough Diseases 0.000 description 1
- 206010013781 dry mouth Diseases 0.000 description 1
- 208000010515 dystocia Diseases 0.000 description 1
- 230000002526 effect on cardiovascular system Effects 0.000 description 1
- 239000002158 endotoxin Substances 0.000 description 1
- 210000003238 esophagus Anatomy 0.000 description 1
- 210000003754 fetus Anatomy 0.000 description 1
- 230000027950 fever generation Effects 0.000 description 1
- 230000002538 fungal effect Effects 0.000 description 1
- 208000003512 furunculosis Diseases 0.000 description 1
- 210000001156 gastric mucosa Anatomy 0.000 description 1
- 235000008434 ginseng Nutrition 0.000 description 1
- 108091005995 glycated hemoglobin Proteins 0.000 description 1
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 1
- 239000010931 gold Substances 0.000 description 1
- 229910052737 gold Inorganic materials 0.000 description 1
- 230000012010 growth Effects 0.000 description 1
- 239000003721 gunpowder Substances 0.000 description 1
- 208000016354 hearing loss disease Diseases 0.000 description 1
- 208000035861 hematochezia Diseases 0.000 description 1
- 230000023597 hemostasis Effects 0.000 description 1
- 208000005252 hepatitis A Diseases 0.000 description 1
- 241000411851 herbal medicine Species 0.000 description 1
- 235000003642 hunger Nutrition 0.000 description 1
- 208000013403 hyperactivity Diseases 0.000 description 1
- 201000001421 hyperglycemia Diseases 0.000 description 1
- 208000006278 hypochromic anemia Diseases 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 230000005847 immunogenicity Effects 0.000 description 1
- 230000008676 import Effects 0.000 description 1
- 201000001881 impotence Diseases 0.000 description 1
- 206010022000 influenza Diseases 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 235000001705 insufficient nutrition Nutrition 0.000 description 1
- 210000000936 intestine Anatomy 0.000 description 1
- 238000010255 intramuscular injection Methods 0.000 description 1
- 239000007927 intramuscular injection Substances 0.000 description 1
- 238000010253 intravenous injection Methods 0.000 description 1
- 230000000302 ischemic effect Effects 0.000 description 1
- 230000003907 kidney function Effects 0.000 description 1
- 230000002147 killing effect Effects 0.000 description 1
- 210000003127 knee Anatomy 0.000 description 1
- 238000009533 lab test Methods 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 210000005229 liver cell Anatomy 0.000 description 1
- 230000003908 liver function Effects 0.000 description 1
- 231100001252 long-term toxicity Toxicity 0.000 description 1
- 239000008629 longdanxiegan Substances 0.000 description 1
- 210000004705 lumbosacral region Anatomy 0.000 description 1
- 239000003550 marker Substances 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 206010027175 memory impairment Diseases 0.000 description 1
- 208000030159 metabolic disease Diseases 0.000 description 1
- 230000029052 metamorphosis Effects 0.000 description 1
- 210000004088 microvessel Anatomy 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 201000002266 mite infestation Diseases 0.000 description 1
- 239000011259 mixed solution Substances 0.000 description 1
- 230000003020 moisturizing effect Effects 0.000 description 1
- VYQNWZOUAUKGHI-UHFFFAOYSA-N monobenzone Chemical compound C1=CC(O)=CC=C1OCC1=CC=CC=C1 VYQNWZOUAUKGHI-UHFFFAOYSA-N 0.000 description 1
- 208000010805 mumps infectious disease Diseases 0.000 description 1
- 230000008693 nausea Effects 0.000 description 1
- 201000008383 nephritis Diseases 0.000 description 1
- 239000002547 new drug Substances 0.000 description 1
- 229960002748 norepinephrine Drugs 0.000 description 1
- SFLSHLFXELFNJZ-UHFFFAOYSA-N norepinephrine Natural products NCC(O)C1=CC=C(O)C(O)=C1 SFLSHLFXELFNJZ-UHFFFAOYSA-N 0.000 description 1
- 229940103453 novolin Drugs 0.000 description 1
- 238000001543 one-way ANOVA Methods 0.000 description 1
- 229940100691 oral capsule Drugs 0.000 description 1
- 230000037040 pain threshold Effects 0.000 description 1
- 206010033675 panniculitis Diseases 0.000 description 1
- NEGYEDYHPHMHGK-UHFFFAOYSA-N para-methoxyamphetamine Chemical compound COC1=CC=C(CC(C)N)C=C1 NEGYEDYHPHMHGK-UHFFFAOYSA-N 0.000 description 1
- 230000009054 pathological process Effects 0.000 description 1
- 230000007170 pathology Effects 0.000 description 1
- 230000004796 pathophysiological change Effects 0.000 description 1
- 230000002093 peripheral effect Effects 0.000 description 1
- 210000000578 peripheral nerve Anatomy 0.000 description 1
- 230000035699 permeability Effects 0.000 description 1
- 210000003800 pharynx Anatomy 0.000 description 1
- 229940023488 pill Drugs 0.000 description 1
- 229940018492 plantago seed Drugs 0.000 description 1
- 229940012957 plasmin Drugs 0.000 description 1
- 239000011505 plaster Substances 0.000 description 1
- 239000004033 plastic Substances 0.000 description 1
- 231100000572 poisoning Toxicity 0.000 description 1
- 230000000607 poisoning effect Effects 0.000 description 1
- 230000035935 pregnancy Effects 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 230000002035 prolonged effect Effects 0.000 description 1
- 229940048914 protamine Drugs 0.000 description 1
- 239000011241 protective layer Substances 0.000 description 1
- 229940039716 prothrombin Drugs 0.000 description 1
- 208000008128 pulmonary tuberculosis Diseases 0.000 description 1
- 230000001047 pyretic effect Effects 0.000 description 1
- 235000012950 rattan cane Nutrition 0.000 description 1
- 235000020995 raw meat Nutrition 0.000 description 1
- 238000010992 reflux Methods 0.000 description 1
- 210000003296 saliva Anatomy 0.000 description 1
- 208000026451 salivation Diseases 0.000 description 1
- 231100000241 scar Toxicity 0.000 description 1
- 230000037387 scars Effects 0.000 description 1
- 210000000453 second toe Anatomy 0.000 description 1
- 230000035807 sensation Effects 0.000 description 1
- 235000019615 sensations Nutrition 0.000 description 1
- 230000001953 sensory effect Effects 0.000 description 1
- 235000011803 sesame oil Nutrition 0.000 description 1
- 239000008159 sesame oil Substances 0.000 description 1
- 229940007046 shigella dysenteriae Drugs 0.000 description 1
- 238000007873 sieving Methods 0.000 description 1
- 210000003491 skin Anatomy 0.000 description 1
- 230000037321 sleepiness Effects 0.000 description 1
- 239000000779 smoke Substances 0.000 description 1
- 210000002460 smooth muscle Anatomy 0.000 description 1
- 238000002791 soaking Methods 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 239000008354 sodium chloride injection Substances 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 238000001179 sorption measurement Methods 0.000 description 1
- 230000007480 spreading Effects 0.000 description 1
- 238000003892 spreading Methods 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 238000007619 statistical method Methods 0.000 description 1
- 208000002254 stillbirth Diseases 0.000 description 1
- 231100000537 stillbirth Toxicity 0.000 description 1
- 230000000638 stimulation Effects 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 210000004304 subcutaneous tissue Anatomy 0.000 description 1
- 238000000967 suction filtration Methods 0.000 description 1
- 238000002636 symptomatic treatment Methods 0.000 description 1
- 208000006379 syphilis Diseases 0.000 description 1
- 231100000057 systemic toxicity Toxicity 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 230000000451 tissue damage Effects 0.000 description 1
- 231100000827 tissue damage Toxicity 0.000 description 1
- 230000008467 tissue growth Effects 0.000 description 1
- 239000008727 tongluo Substances 0.000 description 1
- 208000004371 toothache Diseases 0.000 description 1
- 230000000699 topical effect Effects 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 231100000820 toxicity test Toxicity 0.000 description 1
- 230000002936 tranquilizing effect Effects 0.000 description 1
- 210000004881 tumor cell Anatomy 0.000 description 1
- 238000011144 upstream manufacturing Methods 0.000 description 1
- 210000000626 ureter Anatomy 0.000 description 1
- 206010046901 vaginal discharge Diseases 0.000 description 1
- 230000002792 vascular Effects 0.000 description 1
- 208000019553 vascular disease Diseases 0.000 description 1
- 230000003639 vasoconstrictive effect Effects 0.000 description 1
- 235000015112 vegetable and seed oil Nutrition 0.000 description 1
- 239000008158 vegetable oil Substances 0.000 description 1
- 230000009278 visceral effect Effects 0.000 description 1
- 210000003905 vulva Anatomy 0.000 description 1
- NWONKYPBYAMBJT-UHFFFAOYSA-L zinc sulfate Chemical compound [Zn+2].[O-]S([O-])(=O)=O NWONKYPBYAMBJT-UHFFFAOYSA-L 0.000 description 1
- 229960001763 zinc sulfate Drugs 0.000 description 1
- 229910000368 zinc sulfate Inorganic materials 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
Description
Claims (10)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201210310306.8A CN102861287B (zh) | 2012-08-28 | 2012-08-28 | 一种治疗湿热下注淤血型糖尿病足的中药组合物及其制备方法 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201210310306.8A CN102861287B (zh) | 2012-08-28 | 2012-08-28 | 一种治疗湿热下注淤血型糖尿病足的中药组合物及其制备方法 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN102861287A CN102861287A (zh) | 2013-01-09 |
| CN102861287B true CN102861287B (zh) | 2014-06-25 |
Family
ID=47440602
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201210310306.8A Active CN102861287B (zh) | 2012-08-28 | 2012-08-28 | 一种治疗湿热下注淤血型糖尿病足的中药组合物及其制备方法 |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN102861287B (zh) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN104888001A (zh) * | 2015-05-28 | 2015-09-09 | 陈有伦 | 一种促进伤口愈合的中药组合物 |
| CN104826030A (zh) * | 2015-05-29 | 2015-08-12 | 合肥丰瑞隆生物科技有限公司 | 一种活血泡脚中药粉 |
| CN105327058A (zh) * | 2015-11-02 | 2016-02-17 | 中国人民解放军第四军医大学 | 一种糖尿病足抗感染促愈合膏剂及其制备方法 |
| CN105920190A (zh) * | 2016-04-29 | 2016-09-07 | 马洪星 | 一种治疗烧烫伤的中药药膏 |
| CN112315988A (zh) * | 2020-11-25 | 2021-02-05 | 广州医科大学附属第五医院 | 促进皮肤溃疡创面修复的毛冬青提取物凝胶剂及制备方法 |
| CN116059288A (zh) * | 2022-12-12 | 2023-05-05 | 复旦大学附属中山医院青浦分院 | 一种治疗糖尿病足创面修复的抗菌外敷药物的制备方法 |
Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102309632A (zh) * | 2010-06-29 | 2012-01-11 | 陕西步长制药有限公司 | 一种药物组合物在制备防治糖尿病并发症药物中的应用 |
-
2012
- 2012-08-28 CN CN201210310306.8A patent/CN102861287B/zh active Active
Patent Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102309632A (zh) * | 2010-06-29 | 2012-01-11 | 陕西步长制药有限公司 | 一种药物组合物在制备防治糖尿病并发症药物中的应用 |
Non-Patent Citations (5)
| Title |
|---|
| 刘希德.糖尿病足中药外用方整理研究.《中国中医药现代远程教育》.2010,第8卷(第20期,总第100期),第180页. |
| 李素琴等.桃仁红花煎加减治疗糖尿病足130例.《四川中医》.2005,第23卷(第7期),第70-71页. |
| 桃仁红花煎加减治疗糖尿病足130例;李素琴等;《四川中医》;20051231;第23卷(第7期);第70-71页 * |
| 糖尿病足中药外用方整理研究;刘希德;《中国中医药现代远程教育》;20101031;第8卷(第20期,总第100期);第180页 * |
| 范冠杰.五.糖尿病足.《糖尿病》.人民卫生出版社,2002, * |
Also Published As
| Publication number | Publication date |
|---|---|
| CN102861287A (zh) | 2013-01-09 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN102091203B (zh) | 一种治疗难愈性创面的外用中药制剂及其制备方法 | |
| CN102091258B (zh) | 一种祛除疤痕的中药组合物及其制备方法 | |
| CN102847063B (zh) | 一种治疗气血两虚血瘀型糖尿病足的中药组合物及其制备方法 | |
| CN103520572B (zh) | 一种用于治疗特应性皮炎的中药组合物及其制备方法 | |
| CN105833279A (zh) | 皮肤多种损伤创面治疗的外用药物组合物及其制备方法 | |
| CN103751633B (zh) | 一种治疗下肢静脉曲张的中药组合物及其制备方法 | |
| CN102861287B (zh) | 一种治疗湿热下注淤血型糖尿病足的中药组合物及其制备方法 | |
| CN103860978B (zh) | 一种治疗褥疮的中药制剂及其制备方法 | |
| CN101411826A (zh) | 一种治疗牛皮癣的内用药 | |
| CN102772712B (zh) | 一种治疗热毒炽盛血瘀型糖尿病足的中药组合物 | |
| CN103520655B (zh) | 一种治疗寻常型银屑病的中药组合物及其制备方法 | |
| CN102846824B (zh) | 一种治疗寒湿血瘀阻络型糖尿病足的中药组合物及其制备方法 | |
| CN104906465A (zh) | 一种治疗妇女慢性盆腔炎的中药化瘀组合物及其制备方法 | |
| CN120285064A (zh) | 一种治疗糖尿病足溃疡的药物组合物及其制备方法与应用 | |
| CN102872335A (zh) | 一种治疗糖尿病足的外用中药制剂及其制备方法 | |
| CN116370576A (zh) | 一种伤口修复中药生肌膏及其制备方法 | |
| CN103690799B (zh) | 一种治疗脑梗塞的中药制剂 | |
| CN107648444A (zh) | 一种用于外阴脂溢性皮炎的缓释性透皮给药贴 | |
| CN104306734B (zh) | 治疗糖尿病坏疽外用膏药制剂及其制备方法 | |
| CN118059181B (zh) | 一种中药组合物及其应用 | |
| CN102824599B (zh) | 一种治疗糖尿病引起的各种皮肤溃烂的中药酊剂 | |
| CN108992655A (zh) | 一种消炎祛肿的中药及其制备方法 | |
| CN107496567A (zh) | 一种治疗糖尿病足病的中药制剂及其制备方法 | |
| CN105362944A (zh) | 一种治疗骨科扭挫伤的中药膏剂 | |
| CN107198763A (zh) | 一种防治小腿静脉曲张的外用中药及其制备方法 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| C53 | Correction of patent of invention or patent application | ||
| CB03 | Change of inventor or designer information |
Inventor after: Ding Cuihong Inventor after: Sun Xianghong Inventor after: Wu Yuhui Inventor before: Sun Xianghong |
|
| COR | Change of bibliographic data |
Free format text: CORRECT: INVENTOR; FROM: SUN XIANGHONG TO: DING CUIHONG SUN XIANGHONG WU YUHUI |
|
| GR01 | Patent grant | ||
| C56 | Change in the name or address of the patentee | ||
| CP02 | Change in the address of a patent holder |
Address after: 225400 Jiangsu city of Taizhou province Taixing City Industrial Park Xiangrong Road No. 18 Patentee after: Yang Gaolin Address before: 266033 No. 138, Liu Liu Road, Sifang District, Shandong, Qingdao Patentee before: Yang Gaolin |
|
| TR01 | Transfer of patent right | ||
| TR01 | Transfer of patent right |
Effective date of registration: 20171023 Address after: 401121, 5-, Yubei District, Chongqing, 1 Dragon Street 498 Patentee after: Chongqing Kaituo Technology Development Co.,Ltd. Address before: 225400 Jiangsu city of Taizhou province Taixing City Industrial Park Xiangrong Road No. 18 Patentee before: Yang Gaolin |
|
| TR01 | Transfer of patent right | ||
| TR01 | Transfer of patent right |
Effective date of registration: 20201109 Address after: 226400 Chengcha Town Industrial Concentration Zone, Rudong County, Nantong City, Jiangsu Province Patentee after: Liu Jun Address before: 401147, Yubei District, Chongqing Longxi street, red Kam Avenue 498, Jiale Violet 1 5- commercial Patentee before: CHONGQING KAITUO TECHNOLOGY DEVELOPMENT Co.,Ltd. |
|
| TR01 | Transfer of patent right | ||
| TR01 | Transfer of patent right |
Effective date of registration: 20250221 Address after: No. 36, Group 22, Gangtou Village, Baicha Town, Rudong County, Nantong City, Jiangsu Province, 226000 Patentee after: Rudong Shuzhou liangpin Design Co.,Ltd. Country or region after: China Address before: 226400 industrial concentration area of Wucha Town, Rudong County, Nantong City, Jiangsu Province Patentee before: Liu Jun Country or region before: China |

